A debate is intensifying in France over proposed reforms that would open pharmacy capital to outside investors, with pharmacy professionals and unions calling on lawmakers to reassess the priorities of the legislation. The reform, which has been under discussion in the French parliament, would allow non-pharmacist investors to hold stakes in pharmacy businesses โ a significant departure from the longstanding rule requiring pharmacies to be owned exclusively by licensed pharmacists.
Professional organizations representing French pharmacists have expressed strong reservations about the proposed changes. They argue that the current ownership model is a cornerstone of patient safety, ensuring that those who own and operate pharmacies have a direct professional and ethical responsibility to their clients. Critics of the reform warn that introducing financial investors could prioritize profit over patient care.
Supporters of the reform contend that opening pharmacy capital could help modernize the sector, attract investment for digital health tools and infrastructure, and address the growing issue of pharmacy deserts in rural areas of France. Proponents argue that new capital could fund expansions and improve access to pharmaceutical services in underserved communities.
The debate mirrors similar discussions taking place across Europe, where several countries have already liberalized pharmacy ownership rules to varying degrees. France remains one of the stricter markets in this regard, and any change would represent a landmark shift in how the country regulates its pharmaceutical retail sector.
As of April 2026, no final legislative decision has been confirmed. Pharmacy professionals continue to call for broader consultation and a more measured approach to any reform, emphasizing that patient welfare must remain the central concern of any changes to the sector's ownership structure.
